AskBorsa

SPINALEX results, Q1 2024

Net profit, assets, equity and cash flow for Q1 2024, against the same period a year earlier, from the published financial statements. fiscal year starts in July.

Net profit25.59 millionEGP · +2118.6% vs the same period a year earlier
Total assets913 millionEGP · +35.5% vs the same period a year earlier
Shareholders' equity715 millionEGP · +19.0% vs the same period a year earlier
Operating cash flow-4.12 millionEGP · −158.4% vs the same period a year earlier

In short

  • SPINALEX's net profit for Q1 2024 was about 25.59 million EGP, up +2118.6% from 1.15 million EGP in Q1 2023.
  • Total assets at the end of Q1 2024 were about 913 million EGP, and shareholders' equity about 715 million EGP.
  • Operating cash flow for Q1 2024 was negative at 4.12 million EGP.
Source: the Q1 2024 financial statements

Key lines against the same period a year earlier

This periodQ1 2023Change
Net profit25.59 million1.15 million+2118.6%
Gross profit27.6 million7.41 million+272.4%
Total assets913 million673 million+35.5%
Total liabilities198 million72.95 million+171.3%
Shareholders' equity715 million600 million+19.0%
Total liabilities and equity913 million673 million+35.5%
Operating cash flow-4.12 million7.06 million−158.4%
Investing cash flow-31.31 million11.26 million−378.1%
Financing cash flow-3.95 million-2.33 million−69.7%
Net change in cash-39.38 million15.98 million−346.4%

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.

Official report (PDF)All of SPINALEX's statements, five yearsAsk the AI analyst about SPIN

SPINALEX's Fiscal year 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for SPINALEX